15 Years of ATMPs – Reflecting on the Past, Shaping the Future

Advanced Therapy Medicinal Products (ATMPs) have revolutionized medicine, offering new treatments for once untreatable conditions.

Willem Orye

January 7, 20250 min read

Regulatory Affairs ATMP

About the Author

Willem Orye

View all articles

Navigate Regulatory Complexity with Confidence

Navigate complex regulatory landscapes with expert guidance across pharmaceuticals, medical devices, and IVD.

Share this article

Subscribe to the latest updates in life science

Expert perspectives delivered to your inbox — pick your interests.

No spam, ever. Unsubscribe anytime.

Keep reading

Regulatory AffairsApr 14, 2026

EU and UK Regulatory Submissions: Platforms, Authority Interactions and Timeline Control

Entering Europe after FDA approval? Learn how to manage EU and UK regulatory submissions, authority interactions, and submission timelines efficiently.

Regulatory AffairsClinicalApr 13, 2026

First-in-Human Operational Readiness for Emerging Biotechs: The Minimum Framework You Need

Prepare for First-in-Human trials with the right operational framework. Align safety, governance, and clinical execution to meet regulatory expectations.

Regulatory AffairsPharmacovigilanceApr 12, 2026

Operational Readiness for Europe: PV, QA and MAH Requirements Biotechs Cannot Ignore

Entering the EU market requires more than approval. Discover the pharmacovigilance, quality, and MAH requirements biotechs must prepare before European launch.

We use cookies to enhance your experience

We use essential cookies for site functionality and optional analytics cookies to improve our services. Read our Privacy Policy and Cookie Policy.